Navigation Links
ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology
Date:2/9/2010

nics

ThromboGenics is a biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of eye disease, vascular disease and cancer. The Company's lead product microplasmin is in Phase III clinical development for the non-surgical treatment of back of the eye diseases. Microplasmin is also being evaluated in Phase II clinical development for additional vitreoretinal conditions. In addition, ThromboGenics is developing novel antibody therapeutics in collaboration with BioInvent International; these include TB-402 (Anti-Factor VIII), a long acting anti-coagulant, and TB-403 (anti-PlGF) for cancer.

ThromboGenics has built strong links with the University of Leuven and the Flanders Institute for Biotechnology (VIB) and has exclusive rights to certain therapeutics developed at these institutions. ThromboGenics is headquartered in Leuven, Belgium. The Company is listed on Eurolist by Euronext Brussels under the symbol THR. More information is available at http://www.thrombogenics.com.

Important information about forward-looking statements

Certain statements in this press release may be considered "forward-looking". Such forward-looking statements are based on current expectations, and, accordingly, entail and are influenced by various risks and uncertainties. The Company therefore cannot provide any assurance that such forward-looking statements will materialize and does not assume an obligation to update or revise any forward-looking statement, whether as a result of new information, future events or any other reason. Additional information concerning risks and uncertainties affecting the business and other f
'/>"/>

SOURCE ThromboGenics NV
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ThromboGenics NV - Q3 2009 Business Update
2. ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema (MIVI II DME)
3. ThromboGenics is Shortlisted for "Biotech Company of the Year" and "Licensing Deal of the Year" at Scrip Awards 2009
4. ThromboGenics NV Announces Business Update and Half Year Results 2009
5. ThromboGenics NV: Business Update
6. ThromboGenics Announces Business Update and 2008 Full Year Results
7. ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis
8. ThromboGenics N.V.: Business Update
9. ThromboGenics Announces Half Year Results 2008
10. ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer
11. ThromboGenics Announces Private Investors Acquire 8% Stake in the Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2014)... --  Sterne, Kessler, Goldstein & Fox P.L.L.C. , an ... , announced today that it has filed eleven ... the U.S. Patent and Trademark Office (USPTO) on behalf ... (Nasdaq: BRLI).  These IPR petitions aim to nullify eleven ... These patents have been asserted against GeneDx in patent ...
(Date:8/18/2014)... Global HIV Infection Drug Market and Pipeline Insight ... of HIV infection and the number of deaths due to ... rate across the globe. It has been estimated that the ... in 2013, with the rates for children being even much ... infection rates has been the improved access to antiretroviral drugs ...
(Date:8/18/2014)... , August 18, 2014 ... Bioreactor Systems Market, By Application (Municipal Wastewater Treatment ... Flat Sheet and Multi Tubular), By Configuration (Internal/Submerged ... 2019", published by MarketsandMarkets, The market for membrane ... by 2019, growing at a CAGR of 15.28% ...
(Date:8/18/2014)... 18, 2014 Dyadic International, Inc. ("Dyadic") ... and proprietary technologies are used to develop, manufacture ... bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, ... Statement on Form 10 with the U.S. Securities ... - http://photos.prnewswire.com/prnh/20110621/CL06708LOGO The ...
Breaking Biology Technology:Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc. 2Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc. 3Global HIV Infection Drug Market Overview 2Global HIV Infection Drug Market Overview 3Global HIV Infection Drug Market Overview 4Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 2Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 3Dyadic International Files Form 10 Registration Statement 2Dyadic International Files Form 10 Registration Statement 3Dyadic International Files Form 10 Registration Statement 4
... outstanding share of common stock of Bruker AXS will be ... common stock of Bruker Daltonics or, at the election of ... value, payable 75% in Bruker Daltonics common stock and 25% ... are not being changed in the merger. , ,The combined ...
... labs, technology, research, communication and planning , ,WASHINGTON ... the Department of Health and Human Services has made ... of states, territories and metro areas to respond to ... to receive $25 million, of which almost $16 Million ...
... and Human Services announced last week the development of ... Emerging Infectious Diseases Research. The University of Wisconsin-Madison is ... Midwestern center as part of a $350 million national ... Chicago and Northwestern University will receive $35 million in ...
Cached Biology Technology:Bruker Daltonics and Bruker AXS Announce Merger Agreement 2Wisconsin to Receive $25 Million for Bioterrorism 2UW-Madison Gets Federal Biodefense Funds 2
(Date:8/18/2014)... 2014 Researchers at UT Southwestern Medical Center have found ... a type of molecule known as long non-coding RNA. , ... "rhythms" of many bodily functions, from waking and sleeping to ... 24-hour cycle that is influenced by external cues such as ... RNAs are abundant in many organisms, what they do in ...
(Date:8/18/2014)... indicates older species of coral have more of what ... climate, according to biologists from the University of Texas ... Mayagez., The researchers examined 140 samples of 14 species ... open-access journal PLOS ONE on Aug. 18. ... the UT Arlington Department of Biology, is lead author ...
(Date:8/18/2014)... kill its ant hosts outside their nest to reproduce ... in the vicinity of the colony, ensuring a constant ... Penn State and colleagues at Brazil,s Federal University of ... Previous research shows that Ophiocordyceps camponoti-rufipedis , known ... carpenter ant workers -- Camponotus rufipes -- ...
Breaking Biology News(10 mins):Researchers obtain key insights into how the internal body clock is tuned 2Researchers obtain key insights into how the internal body clock is tuned 3Older coral species more hardy, UT Arlington biologists say 2Zombie ant fungi manipulate hosts to die on the 'doorstep' of the colony 2Zombie ant fungi manipulate hosts to die on the 'doorstep' of the colony 3
... it possible to solve climate change, reduce poverty and save ... dream, but this is exactly the issue that is being ... Bali 3-14 December 2007. The key is to include reduced ... so that developing countries can be compensated for saving their ...
... Topics include: onset of plate tectonics on Earth; Arctic ... the end-Permian mass extinction; Olduvai Basin lake cycles and ... the break-up of Rodinia; relationship between earthquakes and melting ... and cause of the end of the PETM. The ...
... frogs can be crowded out by immigrant or imported ... The scientists investigated water frog populations in France and ... ridibunda), which normally occurs only in Eastern Europe, has ... hybrid frog (Rana grafi) and the Iberian water frog ...
Cached Biology News:Having the climate cake and eating it, too 2December GEOLOGY and GSA TODAY media highlights 2December GEOLOGY and GSA TODAY media highlights 3December GEOLOGY and GSA TODAY media highlights 4December GEOLOGY and GSA TODAY media highlights 5December GEOLOGY and GSA TODAY media highlights 6December GEOLOGY and GSA TODAY media highlights 7December GEOLOGY and GSA TODAY media highlights 8December GEOLOGY and GSA TODAY media highlights 9December GEOLOGY and GSA TODAY media highlights 10Indigenous water frogs under threat 2
...
... measures NOS activity by monitoring the conversion ... is simple, sensitive, and specific for NOS ... crude and purified enzyme preparations. The kit ... total reactions. Radiolabeled arginine and NADPH are ...
Human TSLP MAb (Clone 258136)...
Human Complement Component C5a MAb (Clone 295003)...
Biology Products: